Markston International LLC cut its holdings in Morgan Stanley (NYSE:MS) by 4.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 237,707 shares of the financial services provider’s stock after selling 10,982 shares during the quarter. Morgan Stanley accounts for approximately 1.4% of Markston International LLC’s holdings, making the stock its 26th largest position. Markston International LLC’s holdings in Morgan Stanley were worth $11,481,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. MCF Advisors LLC boosted its holdings in shares of Morgan Stanley by 5.8% during the 2nd quarter. MCF Advisors LLC now owns 3,581 shares of the financial services provider’s stock valued at $173,000 after purchasing an additional 197 shares during the last quarter. Larson Financial Group LLC boosted its holdings in shares of Morgan Stanley by 60.2% during the 2nd quarter. Larson Financial Group LLC now owns 543 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 204 shares during the last quarter. Harbor Investment Advisory LLC boosted its holdings in shares of Morgan Stanley by 6.4% during the 2nd quarter. Harbor Investment Advisory LLC now owns 3,476 shares of the financial services provider’s stock valued at $168,000 after purchasing an additional 209 shares during the last quarter. Sequoia Financial Advisors LLC boosted its holdings in shares of Morgan Stanley by 3.3% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 6,668 shares of the financial services provider’s stock valued at $322,000 after purchasing an additional 213 shares during the last quarter. Finally, Ninety One SA PTY Ltd boosted its holdings in shares of Morgan Stanley by 0.7% during the 2nd quarter. Ninety One SA PTY Ltd now owns 31,717 shares of the financial services provider’s stock valued at $1,518,000 after purchasing an additional 218 shares during the last quarter. 88.70% of the stock is currently owned by institutional investors and hedge funds.

In other news, insider Andrew M. Saperstein sold 28,846 shares of the business’s stock in a transaction dated Friday, July 17th. The shares were sold at an average price of $52.56, for a total transaction of $1,516,145.76. Following the completion of the sale, the insider now owns 118,478 shares of the company’s stock, valued at $6,227,203.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Keishi Hotsuki sold 19,000 shares of the business’s stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $52.00, for a total transaction of $988,000.00. Following the sale, the insider now directly owns 243,666 shares of the company’s stock, valued at approximately $12,670,632. The disclosure for this sale can be found here. Insiders have sold 197,846 shares of company stock valued at $10,362,646 over the last 90 days. 0.26% of the stock is currently owned by insiders.

Several research analysts have commented on the stock. Piper Sandler increased their price objective on shares of Morgan Stanley from $48.00 to $51.00 and gave the company a “neutral” rating in a report on Friday, July 17th. DA Davidson increased their price objective on shares of Morgan Stanley from $58.00 to $64.00 and gave the company a “buy” rating in a report on Friday, July 17th. Oppenheimer reaffirmed a “buy” rating on shares of Morgan Stanley in a report on Tuesday, September 8th. ValuEngine downgraded shares of Morgan Stanley from a “sell” rating to a “strong sell” rating in a report on Thursday, July 2nd. Finally, Wells Fargo & Company reaffirmed a “hold” rating on shares of Morgan Stanley in a report on Sunday, June 7th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $54.32.

Shares of NYSE:MS traded down $0.05 on Friday, hitting $50.20. 644,738 shares of the company were exchanged, compared to its average volume of 14,096,229. Morgan Stanley has a 1-year low of $27.20 and a 1-year high of $57.57. The stock’s 50 day moving average price is $51.20 and its 200 day moving average price is $44.54. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 2.58. The firm has a market capitalization of $79.23 billion, a P/E ratio of 9.06, a price-to-earnings-growth ratio of 1.01 and a beta of 1.46.

Morgan Stanley (NYSE:MS) last posted its quarterly earnings data on Thursday, July 16th. The financial services provider reported $1.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.12 by $0.84. Morgan Stanley had a net margin of 17.78% and a return on equity of 11.90%. The business had revenue of $13.41 billion during the quarter, compared to the consensus estimate of $10.39 billion. During the same period in the previous year, the firm posted $1.23 earnings per share. The business’s revenue for the quarter was up 30.9% compared to the same quarter last year. On average, equities analysts predict that Morgan Stanley will post 5.18 EPS for the current fiscal year.

Morgan Stanley Company Profile

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through Institutional Securities, Wealth Management, and Investment Management segments.

Read More: What is a death cross?

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.